Trade DWTX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Dogwood Therapeutics, Inc. (DWTX) is trading at US$1.94, up 3.19% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$84.64M. Over the past 52 weeks, DWTX has traded between US$1.28 and US$9.50. On Syfe you can trade DWTX with $0 commission and add it to your watchlist.
| Previous close | US$1.88 |
|---|---|
| Market cap | US$84.64M |
| 52-week range | US$1.28 – US$9.50 |
| Volume | 52.39K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Dogwood Therapeutics, Inc.
Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.
Year: 2020
Dogwood Therapeutics Enrolls First 200 Patients in Phase 2b Neuropathic Pain Trial
Jul 20, 1:10 PM · MT Newswires
Dogwood Therapeutics, Inc. (DWTX) stock is trading at US$1.94, +3.19% from the previous close of US$1.88.
The market cap for Dogwood Therapeutics, Inc. (DWTX) stock is approximately US$84.64M.
The 52-week high for Dogwood Therapeutics, Inc. (DWTX) stock is US$9.50.
The 52-week low for Dogwood Therapeutics, Inc. (DWTX) stock is US$1.28.
Dogwood Therapeutics, Inc. (DWTX) does not currently pay a dividend.
Stay on top of DWTX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
